Literature DB >> 11907704

Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men.

P Gillberg1, H Olofsson, H Mallmin, W F Blum, S Ljunghall, A G Nilsson.   

Abstract

Studies on the hormonal regulation of bone metabolism in men have indicated covariation between insulin-like growth factor-I (IGF-I) and sex hormones with bone mineral density (BMD). In this study the relationships between BMD in total body, lumbar spine, femoral neck, distal and ultradistal (UD) radius and circulating levels of IGFs, IGF binding proteins (IGFBPs), and sex steroids were investigated in 55 Swedish men between 22 and 85 (52 +/- 18, mean +/- SD) years of age. BMD in total body, distal and UD radius, and femoral neck was positively correlated with serum IGF-I (r = 0.31 to 0.49), IGF-II (r = 0.32 to 0.48), IGFBP-3 (r = 0.37 to 0.53), and free androgen index (FAI) (r = 0.32 to 0.40), and negatively with IGFBP-1 (r = -0.37 to -0.41) and IGFBP-2 (r = -0.29 to -0.41) levels. A positive correlation was observed between BMD in femoral neck and estradiol/SHBG ratio (r = 0.34, P = 0.01). Age correlated negatively with serum IGF-I, IGF-II, IGFBP-3, FAI, estradiol/SHBG ratio, and BMD in total body, distal and UD radius, and femoral neck, and positively with IGFBP-1, IGFBP-2, and SHBG levels. According to stepwise multiple regression analyses, a combination of weight, IGFBP-3, and testosterone accounted for 43% of the variation in BMD in femoral neck, 34% in ultradistal radius and 48% in total body (P < 0.0001). These findings indicate that sex hormones and the different components of the IGF system are associated with BMD in Swedish men, suggesting that age-related changes in these systems could contribute to the development of osteoporosis in elderly men.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11907704     DOI: 10.1007/s002230020048

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  28 in total

1.  Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.

Authors:  T Yamaguchi; M Kanatani; M Yamauchi; H Kaji; T Sugishita; D J Baylink; S Mohan; K Chihara; T Sugimoto
Journal:  Calcif Tissue Int       Date:  2006-01-06       Impact factor: 4.333

2.  Hepatic osteodystrophy and liver cirrhosis.

Authors:  Vedat Goral; Mehmet Simsek; Nuriye Mete
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

3.  Serum insulin-like growth factor binding protein-1 levels and bone mineral density in older adults: the Rancho Bernardo Study.

Authors:  Simerjot K Jassal; Denise von Muhlen; Elizabeth Barrett-Connor; Clifford J Rosen
Journal:  Osteoporos Int       Date:  2005-08-09       Impact factor: 4.507

Review 4.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

5.  Low levels of plasma IGF-1 inhibit intracortical bone remodeling during aging.

Authors:  Hayden-William Courtland; Oran D Kennedy; Yingjie Wu; Ying Gao; Hui Sun; Mitchell B Schaffler; Shoshana Yakar
Journal:  Age (Dordr)       Date:  2012-09-14

6.  Differential effects of IGF-1 deficiency during the life span on structural and biomechanical properties in the tibia of aged mice.

Authors:  Nicole M Ashpole; Jacquelyn C Herron; Patrick N Estep; Sreemathi Logan; Erik L Hodges; Andriy Yabluchanskiy; Mary Beth Humphrey; William E Sonntag
Journal:  Age (Dordr)       Date:  2016-03-11

7.  The role of IGF-I and IGFBP-1 status and secondary hyperparathyroidism in relation to osteoporosis in elderly Swedish women.

Authors:  H Salminen; M Sääf; H Ringertz; L E Strender
Journal:  Osteoporos Int       Date:  2007-09-14       Impact factor: 4.507

8.  Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene.

Authors:  Francisco J A de Paula; Miburge B Góis-Júnior; Manuel H Aguiar-Oliveira; Francisco de A Pereira; Carla R P Oliveira; Rossana M C Pereira; Catarine T Farias; Tábita A R Vicente; Roberto Salvatori
Journal:  Clin Endocrinol (Oxf)       Date:  2008-05-20       Impact factor: 3.478

Review 9.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

10.  Analysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers.

Authors:  R M Palmer; R F Wilson; P Y Coward; D A Scott
Journal:  Tob Induc Dis       Date:  2002-06-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.